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Abstract
Food allergy appears to have its roots in an insufficient exposure to a diverse range of environmental microbiota
during early life. Microbial exposure ensures the colonization of the gastrointestinal tract with commensal microbes,
which is necessary for the induction of a balanced and tolerogenic immune function. High-throughput sequencing
technology has facilitated in-depth studies of the gut microbiota as well as bacterial-derived metabolites. Although
the role of the microbiota in allergies is now widely studied, its importance for food allergy was only recently noted.
Studies in human cohorts have shown that there is an association of dysbiosis and pathogenesis of food allergy, while
studies from animal models have demonstrated the capacity of specific species in the gut microbiota to alter immune
response, which may lead to the desensitization of food allergy. This article reviews the role of the gut microbiota in
food allergy, and discusses the influence of environmental factors as well as prevention and management strategies
relating to such regulatory mechanism.
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Introduction
For decades, many cultivated microorganisms have been
discovered by the microbiological culture technique, but
these represent only a minority of the microbial species
of the gut. The use of next generation high-throughput sequencing techniques has widened tremendously
our knowledge of the human microbiota composition
and its relationship to disease. The human body is estimated to consist of 10–100 trillion microbes, and more
than 1000 bacterial species [1]. The highest number of
microbes are found in the human gut [2]. The number
of microbes found in the human gut are 10 times the
number of cells making up the human body [3], although
this ratio has been disputed [4]. Studies in the past few
years have identified a critical role of the gut microbiota
in shaping the immune system [5–8]. The gut microbiota is involved in the development of the organs of the
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immune system, and determines the tendencies of host
immune responses. Research on the association between
immune diseases and gut microbiota has reported that
alterations in commensal bacteria can induce changes to
the immune system [2, 9] which affect regulation of host
metabolism, immune system maturation, and development of oral tolerance [10]. Thus, attempts to mitigate
allergic diseases through adjusting the diversity and individuality of the gut microbiota have increased.
This review article outlines recent insights into the role
of the gut microbiota in food allergy, the influence of
environmental factors as well as prevention and management strategies involving the gut microbiota.

Dysbiosis and food allergy
Dysbiosis refers to a change in the microbiota composition and function such that it disrupts gut homeostasis and contributes to diseases [11]. There are
increasing evidence from human studies suggesting
that dysbiosis is associated with pathogenesis of food
allergy (Table 1) [12–23]. Although these studies are
not able to identify specific bacterial taxa that are
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Table 1 Main gut microbiota differences between patients with and without food allergy
Study

Types of food allergy

Association with food allergy

Bunyavanich et al.

Cow’s milk

Savage et al.

Cow’s milk, egg, wheat, soy, nuts

Azad et al.

Cow’s milk, egg, peanut

Hua et al.

Peanut

Inoue et al.

Egg, wheat, soybean, sesame, cow’s milk, peanut, shrimp,
crab

Ling et al.

Cow’s milk, egg, wheat, nut, peanuts, fish, shrimp, soy beans

Chen et al.

Egg white, cow’s milk, wheat, peanut, soy bean

Fazlollahi et al.

Egg

Dong et al.

Cow’s milk

Diaz et al.

Cow’s milk

↓Clostridia, Firmicutes

↓Citrobacter, Oscillospira, Lactococcus, Dorea

↑Enterobacteriaceae
↓Bacteroidaceae

↓Clostridiales
↑Bacteroidales

↓Bacteroidetes, Proteobacteria, Actinobacteria
↑Firmicutes

[12]
[14]
[15]
[16]
[17]
[18]

↓Bacteroidetes
↑Firmicutes

[19]

↑Lactobacillaceae
↓Bifidobacteriaceae, Ruminococcaceae

[115]

↑Lachnospiraceae, Streptococcaceae, Leuconostocaceae [20]

↓Coriobacteriaceae

Berni Carnani et al. Cow’s milk
Kourosh et al.

↓Dorea, Akkermansia
↑Veillonella

References

↑Bacteroides, Alistipes

Tree nuts, fish, milk, egg, sesame, soy

↑Oscillibacter valericigenes, Lachnoclostridium bolteae,
Faecalibacterium sp.

consistently associated with food allergy due to heterogeneity in study design, such as different sampling
time points, different techniques used to characterize
the gut microbiota, and different allergic phenotypes,
these studies show microbiota diversity and composition are significantly associated with the onset of food
allergy.
Until now, it remains unclear how dysbiosis exactly
affects the immune system in the development of
food allergy but studies suggest that the gut microbiota influences the immune system by affecting host
metabolism [2, 24–26] and the alteration of adaptive
immunity [27, 28].

[21]
[22]
[23]

Metabolic and immune effects
Major attention has been directed to the possible role of
short-chain fatty acids, such as butyrate, propionate, and
acetate in affecting the immune system (Table 2) [29–32],
since short-chain fatty acids are the main product of the
digestive action of the gut microbiota [29, 30]. Production of short-chain fatty acids, particularly butyrate, is
able to enhance the Vitamin A metabolism, in turns
inducing the activity of ALDH in CD103+MLN DCs,
and increasing the percentages of T regulatory (Tregs)
cells and increasing IgA production [33]. Meanwhile,
short-chain fatty acids are able to inhibit histone deacetylases activity, resulting in regulation of aldh1a1 expression, which contributes to immune tolerance. Other than
this, short-chain fatty acids can bind metabolite-sensing
G-protein coupled receptors, GPR43 or GPR109A [34],

Table 2 Production of the short-chain fatty acids by the gut microbiota
Short-chain
fatty acids

Pathway

Microbiota

References

Acetate

Acetyl-CoA

Most enteric bacteria

[31]

Wood–Ljungdahl pathway

Blautia hydrogenotrophica

Succinate pathway

Negativicutes, Bacteroidetes

Acrylate pathway

Megasphaera elsdenii, Clostridium propionicum

Propionate

Butyrate

Propanodiol pathway

Salmonella enterica, Roseburia inulinivorans, Ruminococcus obeum

Butyrate kinase and phosphotransbutyrylase

Coprococcus species

Butyryl-coenzyme A (CoA):acetate CoA-transferase

Faecalibacterium prausnitzii, Roseburia spp., Eubacterium rectale,
Eubacterium hallii Anaerostipes spp.

[32]

[31]
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in turn promoting the tolerogenic CD103+ DC function and protecting against food allergies [35]. Moreover,
short-chain fatty acids can reduce the production of proinflammatory cytokines including IL-1β, IL-6, IL-17 [36],
and meanwhile increase the production of anti-inflammatory mediators including IL-10 [36, 37]. Thus, shortchain fatty acids are viewed as a key factor in promoting
immunological tolerance towards harmless antigen and
preventing inflammation.

Adaptive immunity
Adaptive immune responses are divided into two types:
humoral immunity, regulated by B cells [38, 39], and
cell-mediated immunity, regulated by T cells. The role
of Tregs, subset of CD4+ T cells in oral tolerance development to food allergen, have been confirmed in animal
models [40, 41] as well as human studies [42, 43] in which
the induction of allergen-specific Treg cells is highly
associated with a favourable allergy outcome. Microbiota,
especially Clostridia species, in this case, were shown to
be able to induce the production of Tregs [44, 45], which
helps to inhibit allergic inflammation and promote oral
tolerance [12, 46–48].
Specific Taxa related to food allergy across multiple
studies
Bacteroidetes and Firmicutes comprise 90% of the microbiota population [49] and the colonization of these two
microbiota phyla is associated with the pathogenesis of
food allergy [50], as summarized in Table 3.
Bacteroidetes
An association between Bacteroidetes phyla in the gut
and food allergy was found in a few epidemiologic studies [15, 18, 19]. Using gene sequencing methods, these
studies identified that children with various types of food
allergy had a lower relative abundance of Bacteroidetes
compared with healthy children. The exact role of Bacteroidetes is unclear. However, a murine study indicated
that Bacteroides fragilis, a species of Bacteroidetes, was
able to produce polysaccharide A (PSA), which increased
the suppressive capacity of the Treg cells and increased
the production of IL-10 from Foxp3+ T cells [51].
The accumulated IL-10 mediates tolerance at mucosal

surfaces and prevents intestinal inflammation. Further
clinical studies in humans are needed to examine the regulatory role of Bacteroidetes in the development of food
allergy.

Firmicutes
Firmicutes is the largest microbiota phylum containing more than 200 genera [52]. Most of the Firmicutes
detected in the gut belong to the Clostridium clusters
XIVa and IV. Both groups comprise members of the genera Clostridium, Eubacterium and Ruminococcus. Firmicutes are the most important butyrate producer in the
gut and help to reduce inflammation through the inhibition of histone deacetylase [30]. A number of studies
using 16S rRNA gene sequencing have identified a lower
relative abundance of bacterial class Clostridia (bacterial phylum Firmicutes) in children with food allergy
compared to healthy children [12, 13, 53, 54]. It is an
accepted scientific knowledge that Clostridia promotes
the accumulation of Treg cells [44, 45, 47, 55]. However,
a study conducted by Stefka st al [55] demonstrated that
Clostridia elevated IL-22 expression by RAR-related
orphan receptor gamma (RORγt)+ ILCs and T cells,
which in turn increasing an early, innate, barrier protective response. At the same time, Clostridia also elevated
the production of IL-17, which in turn reducing intestinal
epithelial permeability. Contradictory results also exist
that patients with food allergy showed an increase in levels of Clostridia [18, 19, 56]. The genera of Clostridia that
have been identified so far to have an association with
food allergy are Clostridium [13, 18, 19, 53] and Ruminococcus [13, 15, 19, 54]. Diesner et al. reported that mice
tolerant to food allergy have higher abundances of Ruminococcaceae [54] compared with intolerant counterparts,
supporting the potential protective effects of Ruminococcus on food allergy. Nevertheless some discordant results
the Clostridia class is that more clearly involved in mechanism of food tolerance induction and in food allergy
protection.
Early‑life colonization and environmental factors
Some studies argue that the gut microbiota is critical
in early life for the development of the immune system
as well as the development of allergic diseases [15, 18,

Table 3 Gut microbiota taxa and alterations associated with food allergy
Phylum

Class

Genus

Species

Action in the Gut

Bacteroidetes

Bacteroidetes

Bacteroidetes

Bacteroides fragilis

Increase the suppressive capacity of Tregs and
[51]
induce the production of IL-10 from Foxp3+ T cells

Firmicutes

Clostridia

Clostridium
Lactobacillus
Ruminococcus

Promote the accumulation of Tregs

References

[116]
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19, 53, 57]. The gut microbiota is unstable in the first
2–3 years of life during the initial colonization and development of the gut. Disruptions of microbial colonization
during this period have been shown to increase the disease susceptibility during life. After the age of three the
gut microbiota progresses towards an adult-like configuration and it essentially remains stable unless perturbed
[1, 5, 53].
The dramatic rise of food allergy in modern society has
led to the postulation of the hygiene hypothesis [58]. The
hygiene hypothesis proposes that a lack of early childhood exposure to infectious agents suppresses the development of the immune system which leads to the rise of
atopic diseases. Recent work has revisited the hygiene
hypothesis model to include mode of delivery, antibiotic
intake, diet [59] and synthetic chemicals as factors in
altering gut microbiota (Fig. 1).

Mode of delivery
Perturbation of gut microbiota may influence susceptibility to food allergy [60]. It is evidenced that infants born
vaginally are exposed to both maternal fecal and vaginal
microbiota while infants born by caesarean section are
exposed to maternal skin and environmental microbes
only [50]. For instance, infants born by caesarean section
are more likely to have lower abundance of Bacteroides
and higher abundance of Firmicutes. Both Bacteroides
and Firmicutes were revealed to associate with development of food allergy [50]. A population based birth
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cohort study revealed that children born by caesarean
section had a threefold higher chance of developing food
allergy [61]. However, the role of the delivery mode in
influencing the food allergy outcome remains unclear as
the delivery mode only exhibits an effect on the immune
system for the first 90 days [62].

Antibiotic intake
Mothers undergoing a caesarean section are more likely
to receive antibiotics [62], which can perturb the composition of the gut microbiota and modify the risk for allergic outcomes [63].
A number of studies have attempted to elucidate how
antibiotics modify the composition of the gut microbiota
and lead to the pathogenies of food allergy [64–66]. These
studies revealed that antibiotic administration altered
and reduced the microbiota diversity. A study suggested
that antibiotic administration may cause reconstitution
of the flora, thereby resulting in failure of the signal transmission via Toll-like receptor 4 (TLR4) [64]. The inability
to signal via TLR4 resulted in markedly increased peanut-specific IgE and Th2 cytokine responses, contributing to allergic responses. Nevertheless, the association of
antibiotic intake in early life and the development of food
allergy is debated [67]. In a Chicago Family Cohort Food
Allergy study, 1359 families were recruited and structure
questionnaires were administered. This study did not find
any association between antibiotic intake in the first year
of life and the diagnosis of food allergy [67].

Fig. 1 Early-life colonization and environmental factors. The gut microbiota is unstable in the first 2–3 years of life during the initial colonization
and development of the gut. During this period, the gut microbiota is vulnerable to some disruptions such as mode of delivery, antibiotic intake,
diet and synthetic chemicals, which may increase specific IgE, induce pro-inflammatory cytokines, reduce anti-inflammatory cytokines, inhibit the
accumulation of Treg cells, and suppress the tolerogenic CD103+ DC (dendritic cell) functions, contributing to the pathogenesis of food allergy.
After the age of 3 the gut microbiota progresses towards an adult-like configuration and this remains the same throughout the life
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Diet
Diet plays an important role in the establishment of the
gut microbiota and affects allergic symptoms [68, 69].
The dietary intake of infants starts with milk, either
breast milk or formula [70]. Breast milk contains human
milk oligosaccharides which stimulate the growth of Bifidobacterium bifidum [71] and genus Lactobacillus [72],
which are the main probiotic organisms in the gut, forming an acidic environment with enriched short-chain
fatty acids [73]. Consequently, breastfed infants are colonized with Bifidobacteria and Lactobacilli compared with
formula fed infants [74]. Additionally, the breastfeeding duration also has an influence on the development
of food allergy as infants with a very brief breastfeeding duration have a higher risk of developing cow’s milk
allergy [75].
The milk intake is gradually replaced by a solid food
diet that is similar to that of the adult and composed of a
wide-variety of dietary macronutrients such as proteins,
fats, carbohydrates and fibres [76]. These macronutrients
are fundamental in determining microbiota composition
and its effect on health outcomes.
After the introduction of complementary diet, the gut
of infants exhibit more Lactobacillus, Ruminococcus,
Bacteroides, Peptostreptococcus and Clostridium, which
are tryptophan-catabolizing species [77]. Tryptophan
is an amino acid commonly presented in high protein
food, which is required for protein biosynthesis. Tryptophan metabolism plays a fundamental role in regulating the immune response as well as T cell proliferation.
Other than this, tryptophan metabolism also induces
IL-10 receptor-1 (IL-10R1) expression, which is essential
in determining whether cells respond to IL-10, a potent
anti-inflammatory cytokine that inhibits the release of
pro-inflammatory cytokines [78].
Other than protein, fibre can also affect microbiota
composition. The microbiota composition of the human
gut associated with a high fibre diet is different from
that seen with a high fat diet [79]. The gut microbiota
with a high fat diet consisting of animal-based foods
has higher abundance of Alistipes, Bilophila and Bacteroides and lower abundance of Roseburia, Eubacterium
and Ruminococcus at genus level when compared to the
gut microbiota with a high fibre diet [79]. The microbial
conversions of dietary fibre to monosaccharides involve
a number of metabolic pathways catalysed by the enzymatic activities of the gut microbiota and short-chain
fatty acids are the major end-products of these microbial conversions [29, 30]. Mice studies were conducted
in order to investigate the role of dietary fibre in suppressing immune response to food antigens [35, 80]. In
these studies, mice were sensitized with food antigen and
fed with either high fibre diet or no fibre diet. After few
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weeks of exclusion diet, mice receiving high fibre diet,
showed significantly reduced symptoms of food allergy.
Therefore, the “Western” diet with its high fat but low
fibre content is proposed to be one of the reasons for the
high prevalence of food allergy in Western countries [35,
81].

Synthetic chemicals
Synthetic chemicals play a role in perturbing the composition of gut microbiota as microbial metabolism of
chemicals by gut microbiota may cause microbial dysbiosis [82], which in turn triggers allergy reaction [83,
84]. For example, food additives, one of the synthetic
chemicals, are commonly found and used in our food
as antioxidants, colourings, and flavourings, sweeteners and preservatives [83]. Mouse studies have indicated
that such chemicals are associated with increased risks
for food allergy [83, 84]. Food additives inhibited the
accumulation of Treg cells, which is necessary for acquisition of oral tolerance [83]. The food additives also promoted the induction of allergic CD11b+ DCs, reduced
the accumulation of tolerogenic CD103+ DCs as well as
inhibited the induction of CD4+CD25hiT cells. Further
to this, this study also suggested that intake of multiple
food additives could increase the risk of developing food
allergy.
Other synthetic chemicals, such as air pollutants, can
be responsible for increasing the appearance of food
allergy. Higher ambient levels of air pollutants, especially
nitrogen dioxide have been consistently demonstrated to
be associated with the increasing risk of allergies, including food allergies [85–87]. The mechanism of how air
pollutant can cause food allergy remains unknown but
studies suggested that inhaled air pollutants were able
to directly or indirectly modify the composition of gut
microbiota [88], which may cause an increase in the gut
permeability and inflammation. Furthermore, inhaled
air pollutants can lead to a substantial inflammatory
response via reactive oxygen species (ROS) production
and nuclear factor kappa B (NF-κB) activation in GI tract.
Therapeutic strategies
Human [12, 15, 18, 19, 53] and murine [54] models have
demonstrated that study subjects with food allergy have
distinct gut signatures and a different gut microbiota
composition. Moreover, there is growing evidence that
alteration of the gut microbiota may explain the development of food allergy [40, 41]. Microbial colonization
has been shown to promote the induction of Treg cells,
which is necessary to modulate the immune system and
maintain tolerance to self-antigens [40, 41]. Microbiota
may also influence the epigenetic modification of genes.
It has been demonstrated that various forms of epigenetic
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changes, such as DNA methylation and histone modification, regulate the immune system. Also microbial derived
metabolites, such as short-chain fatty acids, have been
shown to reduce pro-inflammatory cytokines and induce
anti-inflammatory mediators as well as inhibit histone
deacetylases [36].
Research indicates that environmental factors affect
the microbiota composition making it an ideal target of
research to find new interventions to desensitize food
allergy.

Probiotic supplementation
The use of probiotic supplementation seems an attractive option for the prevention and treatment of allergic
diseases. Probiotics are defined as “live microorganisms
which, when administered in adequate amounts as part
of food, confer a health benefit on the host” [89, 90]. Probiotics can act as promoters of an adequate balance in
the gut microbiota to prevent the development of allergies. The beneficial effects of probiotics involve restoring
intestinal permeability to normal, improving the intestine’s immunological barrier function (both physical and
mucous layer), promoting IgA production and inhibiting
the release of proinflammatory cytokines through regulating gut microbiota composition [91, 92].
A well-characterised bacterial probiotic in desensitizing food allergy, especially cow’s milk allergy, is Lactobacillus rhamnosus GG [93]. Dietary intervention with
Lactobacillus rhamnosus GG was found to reduce allergic responses towards cow’s milk in murine [94, 95] and
human studies [93, 96, 97]. Lactobacillus rhamnosus GG
was able to increase the production of different cytokines
with proinflammatory (TNF-α and IL-6) or regulatory
(IL-10) functions [98]. In addition, Lactobacillus rhamnosus GG also induced the accumulation of colonic
Treg cells in the intestine [99]. In addition, Lactobacillus
rhamnosus GG was able to increase FoxP3 demethylation rate, increase IL-4 and IL-5 DNA methylation rate,
reduce IL-10 and IFN-γ DNA methylation rate, increase
the expression of miR-155, -146a, -128 and -193a, to promote the acquisition of cow’s milk tolerance 12 months
after treated with extensively hydrolyzed casein formula
containing the probiotic Lactobacillus rhamnosus GG
[97].
One study found that Lactobacillus rhamnosus GG
showed a weak effect in desensitizing peanut allergy
[100]. Most of the participants who received this probiotic and peanut oral immunotherapy passed the oral food
challenge after receiving the treatment for 18 months
and still passed the oral food challenge after 2 to 5 weeks
after that. Moreover, participants who received probiotic
and peanut oral immunotherapy showed a decrease in
peanut sIgE levels and skin prick test wheal size, as well

Page 6 of 11

as an increase in peanut sIgG4 levels, at the end of treatment. Three months after treatment ended, these participants still had low sIgE levels and a small skin prick test
wheal size. However, there was no convincing evidence
that probiotic was effective in reducing allergic reactions
to food as this study only compared between participants who received probiotic and peanut oral immunotherapy and participants who received placebo without
including oral immunotherapy group only and probiotic
group only. Also the prolonged tolerance towards peanut
remains unclear as the participants in this study were not
followed up beyond 3 months.
A mouse model of shellfish allergy demonstrated that
oral administration of the probiotic strain Bifidobacterium longum reduced the specific IgE and stimulated
dendritic cell maturation and CD103+ tolerogenic DCs
accumulation in gut-associated lymphoid tissue. This, in
turn, increased Tregs differentiation and suppressed Th2
responses [95, 101]. A murine study of cow’s milk allergy
showed that oral administration of Bifidobacterium
longum subsp. Infantis LA308 strain induced the expression of IL-10 and skewed the immune response to Th1.
These results are encouraging to find a candidate probiotic strain to perform a clinical trial.
Two other murine studies have reported the capacity of Clostridium butyricum to reduce adverse reactions to egg and cow’s milk [46, 102]. The mechanism
of how Clostridium butyricum is able to inhibit allergic
inflammation remains unknown. Shi [102] suggested
that the therapeutic effect of Clostridium butyricum may
be generated by IL-10, as the IL-10-producing antigen
specific Breg was found in mice with egg allergy which
were administered with specific immunotherapy and
Clostridium butyricum. On the other hand Zhang [46]
suggested that Clostridium butyricum increased sIgA,
CD4+CD25+Foxp3 Treg cell as well as reversed the
imbalance of Th1/Th2 and Th17/Treg. These interesting
results require further validation from human clinical
trials.
There are three limitations on probiotic dietary intervention. First, the effect of probiotic is strain specific
[103] and may vary depending on the individual’s lifestyle and baseline gut microbiota profile [104]. Secondly,
abrupt termination of probiotic dietary intervention may
further increase the gut dysbiosis [105]. Lastly, there are
only a few studies about probiotic dietary intervention
and further studies are needed to validate the findings in
human system.

Prebiotic supplementation
Prebiotic is defined as “nonviable food component that
confers a health benefit on the host through modulation
of the gut microbiota” [106]. An animal study reported
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that cocoa, a source of antioxidant polyphenols, may be
used to desensitize oral allergy [107]. In this study, rats
administered with a 10% cocoa diet achieved oral tolerance and had a lower relative abundance of bacterial phylum Firmicutes and Proteobacteria and a higher relative
abundance of Tenericutes and Cyanobacteria spp. compared to rats who received a standard diet, either orally
sensitized or non-sensitized rats. It was suggested that
the cocoa diet was able to increase the proportion of
TCRγδ+ and CD103+CD8+ cells and decrease the proportion of CD62L+CD4+ and CD62L+CD8+ cells in
mesenteric lymph nodes [108], regulate Treg cells function and reduce IgA production [107] through modulation of gut microbiota. This suggests that a cocoa diet has
potential in regulating allergic immune responses in the
human body and is of interest to investigate further.

Synbiotic supplementation
Synbiotics refers to a mixture of probiotics and prebiotics, designed to improve the survival of the beneficial
microbiota as well as stimulate the growth of beneficial
microbiota in the gastrointestinal tract [106].
A pioneer study tested a prebiotic blend of fructo-oligosaccharides with the probiotic strain Bifidobacterium
breve M-16V. Infants with suspected non-IGE cow’s milk
allergy were administered with a hypoallergenic, nutritionally complete amino-acid based formula either with
or without the synbiotics [109]. The relative abundance
of Bifidobacteria was increased in infants with cow’s milk
allergy who were administered synbiotics. Moreover, the
microbiota profile of these allergic infants became similar to that of healthy breastfed infants. More studies are
required to confirm this therapeutic effect of synbiotics supplementation in desensitizing food allergy. It is
a promising therapeutic strategy for improving the gut
ecosystem and reducing food allergy responses.
Fecal microbiota transplantation
Fecal microbiota transplantation is a possible therapeutic
for food allergy. Transplantation of fecal bacteria from a
healthy donor to a disease recipient can re-establish gut
microbiota diversity leading to the resolution of symptoms [110, 111]. As dysbiosis affects the development of
food allergy [12], restoration of immune homeostasis and
reconstruction of the impaired gut microbiota barrier
by fecal microbiota transplantation may be able to promote the development of oral tolerance [110]. Recently,
a human study has revealed that fecal microbiota transplantation is able to induce remission of infantile allergic
colitis through restoration of gut microbiota diversity
[112]. Although the available data in this field remain limited and the relevant scientific work has only just begun,
this recent success in reducing infantile allergy colitis
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symptoms suggests that fecal microbiota transplantation
can be a feasible strategy to arrest food allergy responses.

Synthetic stool substitute
Considering the strain specific effect of probiotic [103]
and limited patient acceptance of fecal microbiota
transplantation [113], a synthetic stool substitute was
proposed in a pilot study [113]. In this study, a stool substitute with 33 strains was developed based on the fecal
microbiota diversity of a healthy donor, also known as
RePOOPulate. Clostridium difficile infection symptoms
of patients were eradicated after 2–3 days of RePOOPulate treatment and this symptom free state lasted for
6 months. This synthetic stool substitute is so far only
tested on two patients with Clostridium difficile infection, yet its potential benefit of reverting normal bowel
pattern and restoring immune homeostasis may help to
reduce allergic reactions towards food.
Microbiome‑based therapy
Microbiome-based therapy can be viewed as a potential
way in treating food allergy. In a mouse study, germ free
mice were colonized with human feces from infants with
cow’s milk allergy and age and gender matched healthy
infants [114]. Healthy-colonized mice had a higher abundance of Anaerostipes caccae when compared with cow’s
milk allergy colonized mice. Mice were then administered with Anaerostipes caccae in order to further investigate the role of Anaerostipes caccae in regulation of gene
expression. Anaerostipes caccae were able to reduce the
expression of Th2 dependent, antibody (serum BLG-specific IgE and IgG1), Acot12 expression as well as cytokine
responses IL-13 and IL-4, which promoted oral tolerance
towards cow’s milk allergy. This opens up a new perspective of food allergy therapy on human.
Conclusion
Studies have shown that the gut microbiota composition
is vulnerable to disruptions in early life and that associated changes in host-microbiota homeostasis can cause
food allergy. These studies support a regulatory role of
the gut microbiota in the manifestation of food allergy,
particularly in early life, but many questions remain and
the underlying mechanisms are yet to be defined. The
majority of our knowledge stems from animal studies and
more human studies are required to validate the precise
role of the gut microbiota in the development of food
allergy. Evidence is emerging to suggest that therapeutic
strategies in modifying gut microbiota composition are
useful in the prevention, management and treatment of
food allergy. Such strategies are apparent future research
directions for developing prophylactic and therapeutic
approaches against food allergy.
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